A greater proportion of invasive tumors in the <50 years group were mucinous epithelial and nonepithelial cancers, both of which have less propensity to elevate serum CA125 than other ovarian cancer types, likely contributing to poorer test performance in the younger age group [31]. The gene discussed is MUC16; the disease is ovarian carcinoma.